Survival and mortality from oral cancer by anatomical location. A narrative review.
Abstract
Oral cancer is a global problem. It is the sixth most frequent cancer among all types of cancer and can affect different areas of the oral cavity. Survival rates are influenced by various factors, such as: histological type, tumor size, presence of regional and/or distance metastases, and the biological status of the patient. According to WHO, survival rate from oral cancer at 5 years is 53-56%. The objective of this review is to describe the survival and mortality rate from oral cancer by anatomical location at national and global scale. Globally, the survival rate for cancer located at the lips, tongue, floor of the mouth, palate, jaws, alveolar ridge and salivary glands ranged from 0% to 100%. However, Chile has not reported the survival rate for different anatomical locations. No information was found in relation to mortality rates for different anatomical locations in Chile and in the world. It is considered that oral cancer affecting the tongue, floor of the mouth, palate and alveolar ridge have the worst prognosis, and conversely, those affecting the lower lip have the best prognosis.
References
1. WHO [Internet]. Centro de Prensa [Cited 2016]. Available from: http://www.who.int/mediacentre/factsheets/fs297/es/
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cáncer 2015; 136(5): 359-386.
3.WHO [Internet]. International Agency for Research of Cancer [Cited 2015]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
4. CANCER [Internet]. USA: American Cáncer Society. [Cited July 12, 2015]. Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003128-pdf.pdf
5. Zini A, Czerninski R, Sgan-Cohen HD. Oral cáncer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010; 39 (4): 299-305.
6. Neville B, Damm D, Allen C, Chi A, editors. Oral and Maxillofacial Pathology. Fourth Editions. United States: Elsevier Publishers; 2015.
7. Salihu S, Güven O, Gllareva E, Prekazi M, Salihu L. A clinical study on survival rate of patients with squamous cell carcinoma of the lower lip in Kosovo. J Craniomaxillofac Surg. 2014; 42(8): 1773-1777.
8. Jing G, Wu Y, Song H, Ren G, Wang R, Guo W. Primary malignant melanoma of the lip: A report of 48 cases. J Oral Maxillofac Surg. 2015; 73(11): 2232-2240
9. Riera P, Martinez B. Morbilidad y mortalidad por cáncer oral y faríngeo en Chile. Rev Med Chile 2005; 133(5): 555-563.
10. Ramírez V, Vásquez-Rozas P, Ramírez-Eyraud P. Mortalidad por cáncer oral y faríngeo en Chile, años 2002-2010. Rev Clin Periodoncia Implantol Rehabil Oral 2015; 8(2): 133-138.
11. Colil C, Cueto A, Fernandez A, Esguep A. Cáncer Orofaríngeo: Caracterización de la Mortalidad en Urbanizacion Valparaiso-Viña del Mar 2001-2010. Int. J. Odontostomat. 2013; 7(1): 117-123.
12. Rodrigues PC, Miguel MC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR, Lopes MA, Graner E, Salo T, Kowalski LP, Coletta RD. Clinical Paper: Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg. 2014; 43(7): 795-801.
13. Azimi H, Khajehahmadi S, Rahpeyma A. Tongue Squamous Cell Carcinoma: A Clinical Study. Iran J Pathol. 2014; 9(1): 28-32.
14. Capote-Moreno A, Naval L, Muñoz-Guerra MF, Sastre J, Rodríguez-Campo FJ. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma. J Oral Maxillofac Surg. 2010; 68(2): 268-275.
15. Rhodus NL, Kerr AR, Patel K. Oral cáncer: leukoplakia, premalignancy, and squamous cell carcinoma. Dent Clin N Amer. 2014; 58(2): 315-340.
16. Marsiglia H, Haie-Meder C, Sasso G, Mamelle G, Gerbaulet A. Clinical investigation: head and neck: Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience. Int J Radiat Oncol Biol Phys. 2002; 52(5): 1257-1263.
17. Pimenta Amaral TM, da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol. 2004; 40(8): 780-786.
18. Rikimaru F, Matsuo M, Higaki Y, Tomita K. Squamous Cell Carcinoma Management of the Floor of Mouth. Pract Otorhinolaryngol. 2010; 103(8): 721-724
19. Yang X, Reng GX, Zhang CP, Zhou GY, Hu YJ, Yang WJ, Guo W, Li J, Zhong LP. Neck Dissection And Post-Operative Chemotherapy With Dimethyl Triazeno Imidazole Carboxamide And Cisplatin Protocol Are Useful For Oral Mucosal Melanoma. BMC Cáncer 2010; 10: 623.
20. Li Q, Wu D, Liu W, Li H, Liao W, Zhang X, Liu Z, Guo Z, Liu X. Oral and maxillofacial surgery: Survival impact of cervical metastasis in squamous cell carcinoma of hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; (1)116: 23-27.
21. Li Q, Xu T, Gao J, Ye W, Gu M, Hu W, Wang F, Cai X. Surgery alone provides long-term survival rates comparable to those of surgery plus postoperative radiotherapy for patients with adenoid cystic carcinoma of the palate. Oral Oncol. 2011; 47(3): 170-173.
22. Magremanne M, Vervaet C. Mélanome de la muqueuse buccale. Rev Stomatol Chir Maxillofac. 2008; 109(3): 175-177.
23. Nakasato T, Izumisawa M, Akahane A, Kikuchi K, Ehara S, Shoji S, Kogi S, Mizuki H, Sugiyama Y. Combined intra-arterial infusion and systemic chemoradiotherapy for stage IV squamous cell carcinoma of the mandibular gingiva. Jpn J Radiol. 2012; 30(9): 752-761.
24. Patel AA. Is alveolar /gingival squamous carcinoma an aggressive subsite of oral cancer?. J Oral Maxillofac Surg 2008; 66(8): 30-31.
25. Rikimaru F, Matsuo M, Higaki Y, Tomita K, Treatment for squamous cell carcinoma of maxillary gingiva/hard palate and mandibular gingiva. J Jpn Soc Head Neck Surg. 2012; 22(3): 283-286.
26. Lee R, Arshi A, Schwartz H, Christensen R. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg. 2015; 141(5): 470-477.
27. Fernández A, Cordova P, Badenier O, Esguep A. Caracterizacion epidemiologica del cancer oral. Revision de la literatura. J Oral Res. 2015; 4(2):137-145.
28. Steve M, Ernenwein D, Chaine A, Bertolus C, Goudot P, Ruhin-Poncet B. Ostéosarcomes des mâchoires. Rev Stomatol Chir Maxillofac. 2011; 112(5): 286-292.
29. Paparella M, Olvi L, Brandizzi D, Keszler A, Santini-Araujo E, Cabrini R. Osteosarcoma of the jaw: an analysis of a series of 74 cases. Histopathology 2013; 63(4): 551-557.
30. Brachet P, Deleval L, Chantrain G, Loeb I, Saussez S. Régression spontanée d'un lymphome B à grandes cellules palais. Rev Stomatol Chir Maxillofac. 2011; 112(3): 180-182.
31. NIH [Internet]. USA: National Cancer Institute [Cited December 20, 2015]. Available from: http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq
32. Maza-Solano J, Sánchez-Gómez S, Herrero-Salado T, Benavente-Bermudo G, Ventura-Díaz J, de Mingo Fernández E. Clasificación pronóstica de los tumores malignos de glándula parótida. Rev Esp Cir Ora Maxilofac. 2015; In Press
33. Speight P, Barrett A. Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg. 2009; 47(8): 587-593.
34. Pohar S, Venkatesan V, Stitt LW, Hall SF, Hammond JA, Read N, Yoo J, Fung K, Pavamani S. Results in the management of malignant submandibular tumours and guidelines for elective neck treatment. J Otolaryngol Head Neck Surg. 2011; 40(3): 191-195
35. Zdanowski R, Dias FL, Barbosa MM, Lima RA, Faria RA, Loyola AM, Nascimento Souza KC. Sublingual gland tumors: clinical, pathologic, and therapeutic analysis of 13 patients treated in a single institution. Head Neck 2011; 33(4): 476-481
36. Lukšić I, Suton P, Macan D, Dinjar K. Intraoral adenoid cystic carcinoma: is the presence of perineural invasion associated with the size of the primary tumour, local extension, surgical margins, distant metastases, and outcome?. Br J Oral Maxillofac Surg. 2014; 52(3): 214-218.
37. CANCER [Internet]. USA: American Cancer Society. [cited July 12, 2015]. Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003137-pdf.pdf
38. Guzzo M, Locati L, Prott F, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010; 74(2): 134-148.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cáncer 2015; 136(5): 359-386.
3.WHO [Internet]. International Agency for Research of Cancer [Cited 2015]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
4. CANCER [Internet]. USA: American Cáncer Society. [Cited July 12, 2015]. Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003128-pdf.pdf
5. Zini A, Czerninski R, Sgan-Cohen HD. Oral cáncer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010; 39 (4): 299-305.
6. Neville B, Damm D, Allen C, Chi A, editors. Oral and Maxillofacial Pathology. Fourth Editions. United States: Elsevier Publishers; 2015.
7. Salihu S, Güven O, Gllareva E, Prekazi M, Salihu L. A clinical study on survival rate of patients with squamous cell carcinoma of the lower lip in Kosovo. J Craniomaxillofac Surg. 2014; 42(8): 1773-1777.
8. Jing G, Wu Y, Song H, Ren G, Wang R, Guo W. Primary malignant melanoma of the lip: A report of 48 cases. J Oral Maxillofac Surg. 2015; 73(11): 2232-2240
9. Riera P, Martinez B. Morbilidad y mortalidad por cáncer oral y faríngeo en Chile. Rev Med Chile 2005; 133(5): 555-563.
10. Ramírez V, Vásquez-Rozas P, Ramírez-Eyraud P. Mortalidad por cáncer oral y faríngeo en Chile, años 2002-2010. Rev Clin Periodoncia Implantol Rehabil Oral 2015; 8(2): 133-138.
11. Colil C, Cueto A, Fernandez A, Esguep A. Cáncer Orofaríngeo: Caracterización de la Mortalidad en Urbanizacion Valparaiso-Viña del Mar 2001-2010. Int. J. Odontostomat. 2013; 7(1): 117-123.
12. Rodrigues PC, Miguel MC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR, Lopes MA, Graner E, Salo T, Kowalski LP, Coletta RD. Clinical Paper: Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg. 2014; 43(7): 795-801.
13. Azimi H, Khajehahmadi S, Rahpeyma A. Tongue Squamous Cell Carcinoma: A Clinical Study. Iran J Pathol. 2014; 9(1): 28-32.
14. Capote-Moreno A, Naval L, Muñoz-Guerra MF, Sastre J, Rodríguez-Campo FJ. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma. J Oral Maxillofac Surg. 2010; 68(2): 268-275.
15. Rhodus NL, Kerr AR, Patel K. Oral cáncer: leukoplakia, premalignancy, and squamous cell carcinoma. Dent Clin N Amer. 2014; 58(2): 315-340.
16. Marsiglia H, Haie-Meder C, Sasso G, Mamelle G, Gerbaulet A. Clinical investigation: head and neck: Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience. Int J Radiat Oncol Biol Phys. 2002; 52(5): 1257-1263.
17. Pimenta Amaral TM, da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol. 2004; 40(8): 780-786.
18. Rikimaru F, Matsuo M, Higaki Y, Tomita K. Squamous Cell Carcinoma Management of the Floor of Mouth. Pract Otorhinolaryngol. 2010; 103(8): 721-724
19. Yang X, Reng GX, Zhang CP, Zhou GY, Hu YJ, Yang WJ, Guo W, Li J, Zhong LP. Neck Dissection And Post-Operative Chemotherapy With Dimethyl Triazeno Imidazole Carboxamide And Cisplatin Protocol Are Useful For Oral Mucosal Melanoma. BMC Cáncer 2010; 10: 623.
20. Li Q, Wu D, Liu W, Li H, Liao W, Zhang X, Liu Z, Guo Z, Liu X. Oral and maxillofacial surgery: Survival impact of cervical metastasis in squamous cell carcinoma of hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; (1)116: 23-27.
21. Li Q, Xu T, Gao J, Ye W, Gu M, Hu W, Wang F, Cai X. Surgery alone provides long-term survival rates comparable to those of surgery plus postoperative radiotherapy for patients with adenoid cystic carcinoma of the palate. Oral Oncol. 2011; 47(3): 170-173.
22. Magremanne M, Vervaet C. Mélanome de la muqueuse buccale. Rev Stomatol Chir Maxillofac. 2008; 109(3): 175-177.
23. Nakasato T, Izumisawa M, Akahane A, Kikuchi K, Ehara S, Shoji S, Kogi S, Mizuki H, Sugiyama Y. Combined intra-arterial infusion and systemic chemoradiotherapy for stage IV squamous cell carcinoma of the mandibular gingiva. Jpn J Radiol. 2012; 30(9): 752-761.
24. Patel AA. Is alveolar /gingival squamous carcinoma an aggressive subsite of oral cancer?. J Oral Maxillofac Surg 2008; 66(8): 30-31.
25. Rikimaru F, Matsuo M, Higaki Y, Tomita K, Treatment for squamous cell carcinoma of maxillary gingiva/hard palate and mandibular gingiva. J Jpn Soc Head Neck Surg. 2012; 22(3): 283-286.
26. Lee R, Arshi A, Schwartz H, Christensen R. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg. 2015; 141(5): 470-477.
27. Fernández A, Cordova P, Badenier O, Esguep A. Caracterizacion epidemiologica del cancer oral. Revision de la literatura. J Oral Res. 2015; 4(2):137-145.
28. Steve M, Ernenwein D, Chaine A, Bertolus C, Goudot P, Ruhin-Poncet B. Ostéosarcomes des mâchoires. Rev Stomatol Chir Maxillofac. 2011; 112(5): 286-292.
29. Paparella M, Olvi L, Brandizzi D, Keszler A, Santini-Araujo E, Cabrini R. Osteosarcoma of the jaw: an analysis of a series of 74 cases. Histopathology 2013; 63(4): 551-557.
30. Brachet P, Deleval L, Chantrain G, Loeb I, Saussez S. Régression spontanée d'un lymphome B à grandes cellules palais. Rev Stomatol Chir Maxillofac. 2011; 112(3): 180-182.
31. NIH [Internet]. USA: National Cancer Institute [Cited December 20, 2015]. Available from: http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq
32. Maza-Solano J, Sánchez-Gómez S, Herrero-Salado T, Benavente-Bermudo G, Ventura-Díaz J, de Mingo Fernández E. Clasificación pronóstica de los tumores malignos de glándula parótida. Rev Esp Cir Ora Maxilofac. 2015; In Press
33. Speight P, Barrett A. Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg. 2009; 47(8): 587-593.
34. Pohar S, Venkatesan V, Stitt LW, Hall SF, Hammond JA, Read N, Yoo J, Fung K, Pavamani S. Results in the management of malignant submandibular tumours and guidelines for elective neck treatment. J Otolaryngol Head Neck Surg. 2011; 40(3): 191-195
35. Zdanowski R, Dias FL, Barbosa MM, Lima RA, Faria RA, Loyola AM, Nascimento Souza KC. Sublingual gland tumors: clinical, pathologic, and therapeutic analysis of 13 patients treated in a single institution. Head Neck 2011; 33(4): 476-481
36. Lukšić I, Suton P, Macan D, Dinjar K. Intraoral adenoid cystic carcinoma: is the presence of perineural invasion associated with the size of the primary tumour, local extension, surgical margins, distant metastases, and outcome?. Br J Oral Maxillofac Surg. 2014; 52(3): 214-218.
37. CANCER [Internet]. USA: American Cancer Society. [cited July 12, 2015]. Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003137-pdf.pdf
38. Guzzo M, Locati L, Prott F, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010; 74(2): 134-148.
Published
2016-01-18
How to Cite
CANDIA, Jorge; FERNÁNDEZ, Alejandra; KRAEMER, Kim.
Survival and mortality from oral cancer by anatomical location. A narrative review..
Journal of Oral Research, [S.l.], v. 5, n. 1, p. 35-42, jan. 2016.
ISSN 0719-2479.
Available at: <https://joralres.com/index.php/JOralRes/article/view/joralres.2016.007>. Date accessed: 28 apr. 2024.
doi: https://doi.org/10.17126/joralres.2016.007.
Issue
Section
Reviews
Keywords
Survival rate, Mortality rate, Oral cancer, Epidemiology, Squamous Cell Carcinoma.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. © 2024.
